SEC Form 4 · accession 0001181431-15-004701
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Javier Rodriguez
Officer — CEO, Kidney Care
Period of report
Mar 12, 2015
Accepted (ET)
Mar 16, 2015 · 9:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 12, 2015 | M | 4,667 | $31.70 | A | 68,931 | D | |
| Common Stock | Mar 12, 2015 | F | 1,864 | $79.41 | D | 67,067 | D | |
| Common Stock | Mar 12, 2015 | S | 2,803 | $79.40 | D | 64,264 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF1 | $31.70 | Mar 12, 2015 | M | 4,667 | D | Mar 31, 2012 | Mar 31, 2015 | Common Stock | 4,667 | 0 | D |
Explanation of responses
- F1Stock Appreciation Rights, granted on 3/31/10, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 33.3% on the second anniversary of the grant date, and 8.33% every 3 months thereafter.